Serbia

Serbia Clinical Trial Quote Request

Clinical Trials Quote Request

Yes

n/a

n/a

• Clinical Trial Quote Request
• Protocol and Informed Consent Form in English
• Protocol Title in Serbian
• Site List in Serbian and English, inclusive of Full Name(s) of Principal Investigator(s), the Hospital(s)/Site Location(s) Address(es) with Area Code

Policy and certificate typically take up to 1 month for carriers to process so please note this time frame in the submission process. Submission should be made to Newfront at least one month before documents are required.
- A scanned countersigned document is required within 14 days of policy inception.
- In addition, wet-inked signed originals are to be mailed to carrier directly to satisfy local requirements
- Please note that in the event of policy cancellation or non-renewal the premium is 100% fully earned. No refund for policy cancellation

Italy Clinical Trial Quote Request

Clinical Trials Quote Request

Yes

For Medical Device studies limits are:
1.000.0000 €/patient
2.5 to 10.000.000 €/protocol
depending upon the size of the trial

For Drug Studies limits will depend on the number of patients :
5.000.000 €/protocol up to 50 patients
7.500.000 €/protocol from 51 to 200 patients
10.000.000 €/protocol for more than 200 patients

For Medical Device Studies:
2 years (up to 5 years potentially available)

For Drug Studies:
=> Successor liability: The Damage (bodily injury) must occur within 24 months after the end of the study
=> Extended reporting period: A Claim must be made by a patient within 36 months after the end of the study

If the study involves gene therapy, cellular therapy, radio-pharmaceuticals or children, carriers are required to issue policies with tail coverage of at least 10 years. For the latter i.e. children, carriers issue 10 years irrespective if the study also involves adults

• Clinical Trial Quote Request
• Protocol and Informed Consent Form in English
• Protocol Title in Italian
• Site List is preferable in Italian, but English is acceptable, inclusive of Full Name(s) of Principal Investigator(s), the Hospital(s)/Site Location(s) Address(es) with Area Code. This information is for the carrier files only. Will not be listed on the policy documents.